SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 45.18 |
| Enterprise Value ($M) | 4.31 |
| Book Value ($M) | 176.08 |
| Book Value / Share | 3.39 |
| Price / Book | 0.26 |
| NCAV ($M) | 160.45 |
| NCAV / Share | 3.09 |
| Price / NCAV | 0.28 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.33 |
| Return on Assets (ROA) | -0.25 |
| Return on Equity (ROE) | -0.28 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 12.22 |
| Current Ratio | 12.22 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 175.66 |
| Assets | 191.29 |
| Liabilities | 15.21 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -84.85 |
| Net Income | -58.71 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -51.28 |
| Cash from Investing | 53.35 |
| Cash from Financing | 0.31 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Sio Capital Management, LLC | 7.19 | 4.57 | |
| 13G | PFM Health Sciences, LP | 5.00 | ||
| 13G/A | BML Investment Partners, L.P. | 6.30 | 0.00 | |
| 13G/A | ArrowMark Colorado Holdings LLC | 7.08 | 34.38 | |
| 13G/A | BlackRock, Inc. | 2.30 | -64.02 | |
| 13G/A | Jpmorgan Chase & Co | 0.00 | -99.58 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 17,286 | 123,093 | 14.04 | |
| 20,347 | 66,625 | 30.54 | |
| 30,326 | 308,004 | 9.85 | |
| 9,208 | 173,271 | 5.31 | |
| 25,689 | 117,733 | 21.82 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PHAT – Phathom Pharmaceuticals, Inc. | PHVS – Pharvaris N.V. |
| PLRX – Pliant Therapeutics, Inc. | PRAX – Praxis Precision Medicines, Inc. |
| PRLD – Prelude Therapeutics Incorporated |
Financial data and stock pages provided by
Fintel.io